PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Usher Institute, University of Edinburgh, Edinburgh, UK.\', \'Edinburgh Centre for Endocrinology & Diabetes, NHS Lothian, Edinburgh, UK.\', \'Portsmouth Hospital NHS Trust, Portsmouth, UK.\', \'NHS Greater Glasgow and Clyde, Glasgow, UK.\', \'Mills-Peninsula Medical Center, San Mateo, California, USA.\', \'Ipswich Hospital, East Suffolk and North East Essex NHS Trust, Colchester, UK.\', \'University of East Anglia, Norwich, UK.\', \'Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, University of Manchester, Manchester, UK.\', \'Manchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.\', \'Institute of Applied Health Research, University of Birmingham, Birmingham, UK.\', \'Centre for Cardiovascular Sciences, The Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1530/EJE-20-0377EJE-20-0377
?:hasPublicationType
?:journal
  • European journal of endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 32508313
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.892
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all